These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31167658)

  • 21. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
    Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
    Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
    Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions.
    Bryant JM; Doniparthi A; Weygand J; Cruz-Chamorro R; Oraiqat IM; Andreozzi J; Graham J; Redler G; Latifi K; Feygelman V; Rosenberg SA; Yu HM; Oliver DE
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy.
    Christiansen RL; Dysager L; Bertelsen AS; Hansen O; Brink C; Bernchou U
    Radiat Oncol; 2020 Feb; 15(1):32. PubMed ID: 32033574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing local dose perturbations due to gas cavities in magnetic resonance-guided radiotherapy.
    Shortall J; Vasquez Osorio E; Chuter R; Green A; McWilliam A; Kirkby K; Mackay R; van Herk M
    Med Phys; 2020 Jun; 47(6):2484-2494. PubMed ID: 32144781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy.
    Nachbar M; Lo Russo M; Gani C; Boeke S; Wegener D; Paulsen F; Zips D; Roque T; Paragios N; Thorwarth D
    Z Med Phys; 2024 May; 34(2):197-207. PubMed ID: 37263911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technical note: Toward implementation of MR-guided radiation therapy for laryngeal cancer with healthy volunteer imaging and a custom MR-CT larynx phantom.
    Huynh E; Boyle S; Campbell J; Penney J; Mak RH; Schoenfeld JD; Leeman JE; Williams CL
    Med Phys; 2022 Mar; 49(3):1814-1821. PubMed ID: 35090060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. History of Technological Advancements towards MR-Linac: The Future of Image-Guided Radiotherapy.
    Rammohan N; Randall JW; Yadav P
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. End-to-end test of an online adaptive treatment procedure in MR-guided radiotherapy using a phantom with anthropomorphic structures.
    Elter A; Dorsch S; Mann P; Runz A; Johnen W; Spindeldreier CK; Klüter S; Karger CP
    Phys Med Biol; 2019 Nov; 64(22):225003. PubMed ID: 31610529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
    Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
    Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Overview of adaptive radiotherapy in 2019: From implementation to clinical use].
    Badey A; Barateau A; Delaby N; Fau P; Garcia R; De Crevoisier R; Lisbona A
    Cancer Radiother; 2019 Oct; 23(6-7):581-591. PubMed ID: 31473088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
    Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
    Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
    Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
    Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic Resonance Imaging for Target Delineation and Daily Treatment Modification.
    Kashani R; Olsen JR
    Semin Radiat Oncol; 2018 Jun; 28(3):178-184. PubMed ID: 29933877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
    Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
    JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer.
    Künzel LA; Nachbar M; Hagmüller M; Gani C; Boeke S; Zips D; Thorwarth D
    Radiother Oncol; 2021 Jun; 159():197-201. PubMed ID: 33812912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial.
    Regnery S; de Colle C; Eze C; Corradini S; Thieke C; Sedlaczek O; Schlemmer HP; Dinkel J; Seith F; Kopp-Schneider A; Gillmann C; Renkamp CK; Landry G; Thorwarth D; Zips D; Belka C; Jäkel O; Debus J; Hörner-Rieber J
    Radiat Oncol; 2023 May; 18(1):74. PubMed ID: 37143154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.